IP Library Granted Patent US 9,810,623
Granted Patent B2
US 9,810,623 · App. 14/656,046 · Granted Nov 7, 2017

Quantification of a change in assay

Inventors: Roozbeh Ghaffari (Cambridge, MA); Alexander Aranyosi (Medford, MA); Stephen Lee (Cambridge, MA)
Assignee: MC10, Inc.
G01N21/272B01L3/5055B01L3/502715B01L2200/025B01L2300/023B01L2300/0636B01L2300/0816B01L2300/0864G01N35/00871G01N2021/7783G01N2035/00881
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,810,623
App. No.
14/656,046
Granted
Nov 7, 2017
Kind
B2
Abstract

The present invention relates to portable devices for point-of-care diagnostics that can perform measurements on a sample (e.g., blood, serum, saliva, or urine) and relay data to an external device for, e.g., data analysis. The device can comprise a paper-based diagnostic substrate and a base substrate that include electronic circuitry and electronic elements necessary for performing the measurements. The device can also comprise an antenna for near field communication with an external device. Another aspect of the invention relates to methods of using these devices.

Claims (29)

1. A measurement device comprising:

a diagnostic substrate comprising

(a) a sample receiver to receive a sample, wherein the sample receiver is at least partially formed in or disposed on the diagnostic substrate;

(b) a fluidic channel connected to the sample receiver;

(c) a detection region at least partially formed in or disposed on the diagnostic substrate, wherein the detection region is coupled to the sample receiver by the fluidic channel;

(d) a control region at least partially formed in or disposed on the diagnostic substrate, wherein the control region is coupled to the detection region by the fluidic channel, and

a base substrate comprising

(e) an antenna for near-field communication (NFC) at least partially formed in or disposed on the base substrate;

(f) electronic circuitry connected to the antenna and at least partially formed in or disposed on the base substrate, wherein the electronic circuitry generates data as a function of an output signal from the sample or a derivative thereof;

(g) a first portion comprising a first photodetector and a second photodetector connected to the electronic circuitry and at least partially formed in or disposed on the first portion;

(h) a second portion comprising a first light source and a second light source connected to the electronic circuitry and at least partially formed in or disposed on the second portion, wherein the first portion is folded with respect to the second portion whereby the photodetectors and the light sources are aligned such that light from the first light source passes through the detection region and gets detected by the first photodetector, the light from the second light source passes through the control region and gets detected by the second photodetector, and

(i) a thin-film battery connected to the electronic circuitry and configured to provide power to the at least one of the first photodetector and the second photodetector, and to provide power to at least one of the first light source and the second light source.

2. The measurement device of claim 1 , wherein the diagnostic substrate further comprises a reagent to react with the sample or the derivative of the sample.

3. The measurement device of claim 2 , wherein the reagent is a plurality of dyed nanoparticles.

4. The measurement device of claim 1 , further comprising a data storage device connected to the electronic circuitry and configured to store the data.

5. The measurement device of claim 1 , further comprising a sensor coupled to the sample receiver to detect the presence of the sample.

6. The measurement device of claim 5 , wherein the sensor is polled periodically or according to a pre-set schedule to determine the presence of the sample.

7. The measurement device of claim 5 , further comprising a timer coupled to the sensor and the photodetector, wherein the timer is activated for a predetermined time when the sample is detected, the predetermined time representing the amount of time to read the sample, the timer activating at least one of the first photodetector and the second photodetector after the predetermined time has been reached, the activated photodetector outputting a measurement value.

8. The measurement device of claim 7 , wherein the sensor is deactivated after the predetermined time.

9. The measurement device of claim 1 , further comprising a housing for enclosing at least a portion of the measurement device.

10. The measurement device of claim 1 , wherein the measurement device is initiated by an external device through a first NFC transaction.

11. The measurement device of claim 10 , wherein the measurement device transmits the data to the external device through a second NFC transaction, whereby the external device processes the data to provide quantitative information related to the sample.

12. The measurement device of claim 10 or 11 , wherein the external device is a hand-held device or a wearable device.

13. The measurement device of claim 11 , wherein the quantitative information comprises at least one of: a glucose level; a T-cell concentration; a microorganism concentration; a water-based pathogen concentration; a bovine serum albumin (BV A) concentration; a bacterial concentration; a viral load; an antigen level; an antibody level; a diagnosis of tuberculosis; a diagnosis of dengue fever; a cardiac enzyme concentration; and a diagnosis of malaria.

14. The measurement device of claim 1 , wherein the first portion is folded over the second portion such that the first portion and the second portion sandwich the diagnostic substrate.

15. The measurement device of claim 1 , wherein the second portion is folded over the first portion such that the first portion and the second portion sandwich the diagnostic substrate.

16. The measurement device of claim 1 , wherein the sample is a fluid sample.

17. The measurement device of claim 16 , wherein the fluid sample is selected from the group consisting of blood, serum, saliva, and urine.

18. The measurement device of claim 1 , wherein the diagnostic substrate comprises a paper-based portion.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Nov 18, 2020
From: BRAEMAR ENERGY VENTURES III, L.P.; NORTH BRIDGE VENTURE PARTNERS VI, L.P.; NORTH BRIDGE VENTURE PARTNERS 7, L.P.; ABERDARE VENTURES IV, LP; ABERDARE PARTNERS IV, LP; WINDHAM LIFE SCIENCES PARTNERS, LP; WINDHAM-MC INVESTMENT I, LLC; LABORATORY CORPORATION OF AMERICA HOLDINGS
To: MC10, INC.
Reel/Frame 054456/0903 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2020
From: MC10, INC.
To: MEDIDATA SOLUTIONS, INC.
Reel/Frame 054476/0075 →
SECURITY INTEREST Recorded Apr 2, 2020
From: MC10, INC.
To: BRAEMAR ENERGY VENTURES III, L.P.; NORTH BRIDGE VENTURE PARTNERS VI, L.P.; NORTH BRIDGE VENTURE PARTNERS 7, L.P.; ABERDARE VENTURES IV, LP; ABERDARE PARTNERS IV, LP; WINDHAM LIFE SCIENCES PARTNERS, LP; WINDHAM-MC INVESTMENT I, LLC; LABORATORY CORPORATION OF AMERICA HOLDINGS
Reel/Frame 052296/0969 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 21, 2017
From: GHAFFARI, ROOZBEH; LEE, STEPHEN; ARANYOSI, ALEXANDER
To: MC10, INC.
Reel/Frame 041661/0252 →
Continuity (3)
Provisional Application 61952076 · Mar 12, 2014
Provisional Application 61952082 · Mar 12, 2014
Related Publication 20150260713A1 · Sep 17, 2015